Literature DB >> 27698514

Synthesis of Psoralidin derivatives and their anticancer activity: First synthesis of Lespeflorin I1.

Pallab Pahari1, Ujwal Pratim Saikia2, Trinath Prasad Das3, Chendil Damodaran3, Jurgen Rohr4.   

Abstract

Synthetic scheme for the preparation of a number of different derivatives of anticancer natural product Psoralidin is described. A convergent synthetic approach is followed using simple starting materials like substituted phenyl acetic esters and benzoic acids. The developed synthetic route leads us to complete the first synthesis of an analogous natural product Lespeflorin I1, a mild melanin synthesis inhibitor. Preliminary bioactivity studies of the synthesized compounds are carried out against two commonly used prostate cancer cell lines. Results show that the bioactivity of the compounds can be manipulated by the simple modification of the functional groups.

Entities:  

Year:  2016        PMID: 27698514      PMCID: PMC5044874          DOI: 10.1016/j.tet.2016.04.066

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  35 in total

1.  Cabazitaxel.

Authors:  Matthew D Galsky; Argyris Dritselis; Peter Kirkpatrick; William K Oh
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

2.  Cytotoxic constituents of Psoralea corylifolia.

Authors:  W Mar; K H Je; E K Seo
Journal:  Arch Pharm Res       Date:  2001-06       Impact factor: 4.946

3.  [Study on effect of psoralidin on anti-experimental postmenopausal osteoporosis and its mechanism].

Authors:  Jin-Ping Li; Xiao-Jing Wang; Ying Zeng; Qing Lin; Xin-Min Mo; Shi-Jie Liu; Jun Yang
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2013-06

4.  Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia.

Authors:  Ewelina Szliszka; Zenon P Czuba; Łukasz Sędek; Andrzej Paradysz; Wojciech Król
Journal:  Pharmacol Rep       Date:  2011       Impact factor: 3.024

Review 5.  Psoralea corylifolia L. (Buguchi) - folklore to modern evidence: review.

Authors:  Bhawna Chopra; Ashwani Kumar Dhingra; Kanaya Lal Dhar
Journal:  Fitoterapia       Date:  2013-07-04       Impact factor: 2.882

6.  Combined directed ortho and remote metalation-Suzuki cross-coupling strategies. Efficient synthesis of heteroaryl-fused benzopyranones from biaryl O-carbamates.

Authors:  Clint A James; Antonio Luiz Coelho; Matt Gevaert; Pat Forgione; Victor Snieckus
Journal:  J Org Chem       Date:  2009-06-05       Impact factor: 4.354

7.  Transcriptional regulation of corticotrophin releasing factor gene by furocoumarins isolated from seeds of Psoralea corylifolia.

Authors:  Yangchao Chen; Yuen-Ting Cheung; Ling-dong Kong; Tzi Bun Ng; Chunfeng Qiao; Shi-fu Mo; Hong-xi Xu; Hsiang-fu Kung
Journal:  Life Sci       Date:  2008-04-01       Impact factor: 5.037

8.  GLIPR1-ΔTM synergizes with docetaxel in cell death and suppresses resistance to docetaxel in prostate cancer cells.

Authors:  Styliani Karanika; Theodoros Karantanos; Shinji Kurosaka; Jianxiang Wang; Takahiro Hirayama; Guang Yang; Sanghee Park; Alexei A Golstov; Ryuta Tanimoto; Likun Li; Timothy C Thompson
Journal:  Mol Cancer       Date:  2015-06-19       Impact factor: 27.401

9.  The coumarin psoralidin enhances anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

Authors:  Joanna Bronikowska; Ewelina Szliszka; Dagmara Jaworska; Zenon P Czuba; Wojciech Krol
Journal:  Molecules       Date:  2012-05-29       Impact factor: 4.411

10.  The pro-apoptotic role of autophagy in breast cancer.

Authors:  S Suman; T P Das; R Reddy; A M Nyakeriga; J E Luevano; D Konwar; P Pahari; C Damodaran
Journal:  Br J Cancer       Date:  2014-06-19       Impact factor: 7.640

View more
  1 in total

Review 1.  Lead Phytochemicals for Anticancer Drug Development.

Authors:  Sukhdev Singh; Bhupender Sharma; Shamsher S Kanwar; Ashok Kumar
Journal:  Front Plant Sci       Date:  2016-11-08       Impact factor: 5.753

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.